Please login to the form below

Not currently logged in

Biohaven Pharmaceuticals

This page shows the latest Biohaven Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Pfizer snaps up Biohaven’s migraine drug for $1.24bn

Pfizer snaps up Biohaven’s migraine drug for $1.24bn

Neuroscience specialist Biohaven Pharmaceuticals has teamed up with Pfizer to commercialise its recently launched migraine drug Nurtec ODT (rimegepant) outside the United States. ... Moving forwards, Biohaven will continue to lead research and

Latest news

  • Biohaven gets FDA approval for migraine drug Nurtec ODT Biohaven gets FDA approval for migraine drug Nurtec ODT

    Biohaven Pharma has become the second drugmaker to bring an oral CGRP inhibitor to the US market for acute migraine, after the US Food and Drug Administration (FDA) approved its Nurtec ... Biohaven says Nurtec ODT (rimegepant) – its first commercial

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Cortellis Drugs to Watch in 2020 report Cortellis Drugs to Watch in 2020 report

    1. Rimegepant from BioHaven Pharmaceuticals is an antagonist of calcitonin gene-related peptide (CGRP), recently approved in the US for the acute treatment of migraine, with prevention trials also ongoing. ... Eli Lilly/Dong Pharmaceuticals’ 5-HT1f

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts


Add my company
IPG Health Medical Communications

We are the world's most celebrated and awarded Medical Communications agencies. We are 800 experts obsessed with combining science, creativity...

Latest intelligence

Humancomms for humancare?
Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
Rare diseases: not so rare after all
The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....